Fatty liver disrupts glycerol metabolism in gluconeogenic and lipogenic pathways in humans

J Lipid Res. 2018 Sep;59(9):1685-1694. doi: 10.1194/jlr.M086405. Epub 2018 Jul 27.


It is a challenge to assess metabolic dysregulation in fatty liver of human patients prior to clinical manifestations. Here, we recruited obese, but otherwise healthy, subjects to examine biochemical processes in the liver with simple triglyceride accumulation using stable isotopes and NMR analysis of metabolic products in blood. Intrahepatic triglycerides were measured using 1H magnetic resonance spectroscopy, and volunteers received 2H2O and [U-13C3]glycerol orally, followed by a series of blood draws. NMR analysis of plasma triglycerides and glucose provided detailed information about metabolic pathways in patients with simple hepatic steatosis. Compared with subjects with low hepatic fat, patients with hepatic steatosis were characterized by the following: lower 13C enrichments in the glycerol backbones of triglycerides (i.e., TG-[13C]glycerol), higher [U-13C3]glycerol metabolism through the tricarboxylic acid (TCA) cycle, delayed gluconeogenesis from [U-13C3]glycerol, and less flexibility in adjusting supporting fluxes of glucose production upon an oral load of glycerol. In summary, simple hepatic steatosis was associated with enhanced [U-13C3]glycerol metabolism through pathways that intersect the TCA cycle and delayed gluconeogenesis from glycerol.

Keywords: glucose; nonalcoholic fatty liver disease; nuclear magnetic resonance; tricarboxylic acid cycle; triglycerides.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Fatty Liver / metabolism*
  • Female
  • Gluconeogenesis*
  • Glycerol / metabolism*
  • Humans
  • Lipogenesis*
  • Male
  • Middle Aged
  • Young Adult


  • Glycerol